Beryllium Chemical Speciation and its Impact on Biological Toxicity and Chronic Beryllium Disease (CBD)

Abstract

Beryllium (Be²⁺) is a highly toxic metal ion, exposure to which can lead to Chronic Beryllium Disease (CBD), a debilitating inflammatory lung disorder. The toxicity of beryllium is fundamentally rooted in its unique coordination chemistry in aqueous solutions. This review provides a comprehensive analysis of beryllium aqueous chemistry and its speciation in binary systems with biologically relevant ligands (amino acids and dicarboxylates), detailing how these chemical properties dictate the metal's bioavailability. Chemically, the high charge density of Be²⁺ drives aggressive hydrolysis, leading to stable polynuclear species such as Be₃(OH)₃³⁺ at physiological pH. Be²⁺ exhibits a strong preference for tetrahedral coordination with "hard" oxygen donors. Speciation studies highlight that complexes forming six-membered chelate rings (e.g., malonate) exhibit higher stability than five-membered rings (e.g., oxalate) due to lower angular strain and better fit with the ion's natural geometry. Biologically, CBD is driven by beryllium-specific CD4⁺ T lymphocytes, where Be²⁺ acts as a neoantigen by inserting into the HLA-DP2/peptide complex. Furthermore, beryllium acts as a potent enzyme inhibitor by displacing essential Mg²⁺ or Zn²⁺ ions from active sites. In conclusion, a detailed understanding of beryllium speciation and coordination equilibria is essential for elucidating its in vivo behavior and forms the basis for the rational design of selective chelating agents to develop effective therapeutic strategies against CBD.